Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (2): 107-112.doi: 10.3969/j.issn.1000-6621.2021.02.002
• Original Articles • Previous Articles Next Articles
WANG Qian, LI Tao, DU Xin(), NI Ni, ZHAO Yan-lin, ZHANG Hui(
)
Received:
2020-11-12
Online:
2021-02-10
Published:
2021-02-03
Contact:
DU Xin,ZHANG Hui
E-mail:duxin@chinacdc.cn;zhanghui@chinacdc.cn
WANG Qian, LI Tao, DU Xin, NI Ni, ZHAO Yan-lin, ZHANG Hui. The analysis of national tuberculosis reported incidence and mortality, 2015—2019[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 107-112. doi: 10.3969/j.issn.1000-6621.2021.02.002
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.02.002
年份 | 人口数 (万) | 报告发病数(例) | 报告发病率(/10万) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
肺结核 | 利福平 耐药 | 涂阳 | 菌阴 | 未痰检 | 仅培阳 | 肺结核 | 利福平 耐药 | 涂阳 | 菌阴 | 未痰检 | 仅培阳 | |||
2015 | 136247 | 864015 | - | 244343 | 535914 | 80933 | 2825 | 63.42 | - | 17.93 | 39.33 | 5.94 | 0.21 | |
2016 | 137078 | 836236 | - | 234457 | 523941 | 74353 | 3485 | 61.00 | - | 17.10 | 38.22 | 5.42 | 0.25 | |
2017 | 137984 | 835193 | 7607 | 231613 | 516967 | 73924 | 5082 | 60.53 | 0.55 | 16.79 | 37.47 | 5.36 | 0.37 | |
2018 | 138910 | 823342 | 15028 | 229102 | 486826 | 59077 | 33309 | 59.27 | 1.08 | 16.49 | 35.05 | 4.25 | 2.40 |
地区 | 2015年 | 2019年 | 报告发病率的 年均递降率 (%) | ||||
---|---|---|---|---|---|---|---|
人口数 (万) | 报告发病数 (例) | 报告发病率 (/10万) | 人口数 (万) | 报告发病数 (例) | 报告发病率 (/10万) | ||
甘肃 | 2591 | 14228 | 54.92 | 2637 | 9542 | 36.18 | 8.01 |
黑龙江 | 3833 | 33242 | 86.73 | 3773 | 22474 | 59.57 | 7.24 |
吉林 | 2752 | 15537 | 56.46 | 2704 | 10810 | 39.98 | 6.67 |
贵州 | 3508 | 46817 | 133.46 | 3600 | 36904 | 102.51 | 5.14 |
广东 | 10724 | 79485 | 74.12 | 11346 | 66261 | 58.40 | 4.66 |
江苏 | 7960 | 31456 | 39.52 | 8051 | 25159 | 31.25 | 4.59 |
湖北 | 5816 | 45448 | 78.14 | 5917 | 36617 | 61.88 | 4.56 |
山西 | 3648 | 15439 | 42.32 | 3718 | 12598 | 33.88 | 4.35 |
河南 | 9436 | 59199 | 62.74 | 9605 | 49753 | 51.80 | 3.76 |
安徽 | 6083 | 35550 | 58.44 | 6324 | 30767 | 48.65 | 3.60 |
山东 | 9789 | 32361 | 33.06 | 10047 | 27800 | 27.67 | 3.50 |
广西 | 4754 | 45835 | 96.41 | 4926 | 39962 | 81.12 | 3.39 |
河北 | 7384 | 34046 | 46.11 | 7557 | 29652 | 39.24 | 3.18 |
宁夏 | 662 | 2794 | 42.23 | 688 | 2536 | 36.86 | 2.68 |
地区 | 2015年 | 2019年 | 报告发病率的 年均递降率 (%) | ||||
人口数 (万) | 报告发病数 (例) | 报告发病率 (/10万) | 人口数 (万) | 报告发病数 (例) | 报告发病率 (/10万) | ||
四川 | 8140 | 54645 | 67.13 | 8341 | 50337 | 60.35 | 2.11 |
浙江 | 5508 | 27982 | 50.80 | 5737 | 26270 | 45.79 | 2.06 |
新疆 | 2298 | 42413 | 184.56 | 2487 | 42043 | 169.05 | 1.74 |
海南 | 903 | 8847 | 97.92 | 934 | 8429 | 90.25 | 1.62 |
重庆 | 2991 | 22435 | 75.01 | 3102 | 22398 | 72.21 | 0.76 |
上海 | 2426 | 6685 | 27.56 | 2424 | 6476 | 26.72 | 0.62 |
福建 | 3806 | 17057 | 44.82 | 3941 | 17286 | 43.86 | 0.43 |
陕西 | 3775 | 21388 | 56.66 | 3864 | 21467 | 55.56 | 0.39 |
辽宁 | 4391 | 23589 | 53.72 | 4359 | 22994 | 52.75 | 0.36 |
江西 | 4542 | 32534 | 71.63 | 4648 | 32905 | 70.79 | 0.23 |
湖南 | 6737 | 55919 | 83.00 | 6899 | 56620 | 82.07 | 0.23 |
北京 | 2149 | 6879 | 32.01 | 2154 | 6941 | 32.22 | -0.13 |
内蒙古 | 2505 | 11950 | 47.70 | 2534 | 12635 | 49.86 | -0.89 |
青海 | 583 | 7191 | 123.34 | 603 | 8115 | 134.58 | -1.77 |
云南 | 4714 | 25651 | 54.41 | 4830 | 29842 | 61.78 | -2.57 |
天津 | 1517 | 2961 | 19.52 | 1560 | 3897 | 24.98 | -5.06 |
西藏 | 318 | 4452 | 140.00 | 344 | 6274 | 182.38 | -5.40 |
年份 | 男性 | 女性 | 合计 | ||||||
---|---|---|---|---|---|---|---|---|---|
<15岁 | 15~59岁 | ≥60岁 | <15岁 | 15~59岁 | ≥60岁 | <15岁 | 15~59岁 | ≥60岁 | |
2015 | 3571 (0.60) | 392416 (65.85) | 199952 (33.55) | 3290 (1.23) | 183438 (68.43) | 81348 (30.34) | 6861 (0.79) | 575854 (66.65) | 281300 (32.56) |
2016 | 3452 (0.60) | 378220 (65.61) | 194758 (33.79) | 3317 (1.28) | 175512 (67.55) | 80977 (31.17) | 6769 (0.81) | 553732 (66.22) | 275735 (32.97) |
2017 | 3558 (0.62) | 372571 (64.45) | 201918 (34.93) | 3479 (1.35) | 171379 (66.65) | 82288 (32.00) | 7037 (0.84) | 543950 (65.13) | 284206 (34.03) |
2018 | 3842 (0.68) | 358157 (63.35) | 203367 (35.97) | 3749 (1.45) | 168469 (65.31) | 85758 (33.24) | 7591 (0.92) | 526626 (63.96) | 289125 (35.12) |
2019 | 3956 (0.74) | 339350 (63.55) | 190675 (35.71) | 4160 (1.72) | 159790 (66.09) | 77833 (32.19) | 8116 (1.05) | 499140 (64.34) | 268508 (34.61) |
合计 | 18379 (0.65) | 1840714 (64.59) | 990670 (34.76) | 17995 (1.40) | 858588 (66.83) | 408204 (31.77) | 36374 (0.88) | 2699302 (65.29) | 1398874 (33.83) |
年份 | 农民 | 家务及待业 | 学生 | 离退休人员 | 工人 | 其他 |
---|---|---|---|---|---|---|
2015 | 556643(64.42) | 106509(12.33) | 34260(3.97) | 39691(4.59) | 33708(3.90) | 93204(10.79) |
2016 | 533637(63.81) | 106593(12.75) | 36094(4.32) | 38959(4.66) | 31779(3.80) | 89174(10.66) |
2017 | 520003(62.26) | 113685(13.61) | 40656(4.87) | 40624(4.87) | 31346(3.75) | 88879(10.64) |
2018 | 505664(61.42) | 112471(13.66) | 48289(5.86) | 40278(4.89) | 29599(3.59) | 87041(10.58) |
2019 | 465945(60.06) | 111006(14.31) | 47732(6.15) | 41324(5.33) | 27737(3.58) | 82020(10.57) |
合计 | 2581892(62.44) | 550264(13.31) | 207031(5.01) | 200876(4.86) | 154169(3.73) | 440318(10.65) |
[1] | 宋红焕, 邵燕, 李燕, 等. 两种分子诊断技术对提高结核病病原学检测阳性率的评价研究. 结核病与肺部健康杂志, 2019,8(3):168-171. doi: 10.3969/j.issn.2095-3755.2019.03.004. |
[2] | World Health Organization. Global tuberculosis report 2020. Geneva:World Health Organization, 2020. |
[3] | Mamishi S, Pourakbari B, Moradzadeh M, et al. Prevalence of active tuberculosis infection in transplant recipients: A systematic review and meta-analysis. Microb Pathog, 2020,139:103894. doi: 10.1016/j.micpath.2019.103894. |
[4] | World Health Organization. End TB strategy. Geneva:World Health Organization, 2015. |
[5] | World Health Organization. Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals. Geneva:World Health Organization, 2015. |
[6] | World Health Organization. Implementing the End TB Strategy. Geneva:World Health Organization, 2015. |
[7] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017 结核病分类. 2017-11-09. |
[8] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[9] | 中华人民共和国国家卫生和计划生育委员会. 国家卫生计生委办公厅关于调整肺结核传染病报告分类的通知.国卫办疾控函〔2017〕600号. 2017-06-15. |
[10] | 中华人民共和国国家卫生健康委. 国家卫生健康委办公厅关于调整肺结核传染病报告分类的通知.国卫办疾控函〔2019〕296号. 2019-03-21. |
[11] | Li T, Chen W, Zhao Y, et al. Underreporting of Notifiable Pulmonary Tuberculosis Cases to the National Tuberculosis Information Management System—China, 2015. China CDC Wkly, 2020,2(12):185-189. doi: 10.46234/ccdcw2020.049. |
[12] | 周林, 刘二勇, 孟庆琳, 等. 《WS 288—2017肺结核诊断》标准实施后肺结核诊断质量评估分析. 中国防痨杂志, 2020,42(9):910-915. doi: 10.3969/j.issn.1000-6621.2020.09.005. |
[13] | 王保前, 李自炜. 农村居民医疗卫生服务满意度影响因素分析. 医学与社会, 2019,32(7):28-31. doi: 10.13723/j.yxysh.2019.07.007. |
[14] | 郑文静, 幺鸿雁, 刘剑君. 《农村居民健康体检指南》团体标准解读. 中国防痨杂志, 2020,42(1):17-18. doi: 10.3969/j.issn.1000-6621.2020.01.006. |
[15] | 成君, 刘剑君. 我国学校结核病疫情监测和预警的现状与进展. 中国防痨杂志, 2020,42(5):436-441. doi: 10.3969/j.issn.1000-6621.2020.05.005. |
[16] | 陈卉, 夏愔愔, 张灿有, 等. 2014—2018年全国学生肺结核疫情变化趋势及特征分析. 中国防痨杂志, 2019,41(6):662-668. doi: 10.3969/j.issn.1000-6621.2019.06.013. |
[17] | 李娅茹, 靳晓伟, 魏晓慧, 等. 一起学校结核病聚集性疫情的流行病学调查及处置. 结核与肺部疾病杂志, 2020,1(1):82-92. doi: 10.3969/j.issn.2096-8493.2020.01.018. |
[18] | 刘二勇, 王前, 周林, 等. 我国部分地区病原学检测阴性肺结核诊断质量现状分析. 中国防痨杂志, 2020,42(9):916-920. doi: 10.3969/j.issn.1000-6621.2020.09.006. |
[19] | 王前, 周林, 刘二勇, 等. 我国县级结核病定点医疗机构结核病诊断能力现况调查研究. 中国防痨杂志, 2020,42(9):926-930. doi: 10.3969/j.issn.1000-6621.2020.09.006. |
[20] | 国家卫生健康委, 国家发展改革委, 教育部, 等. 关于印发遏制结核病行动计划(2019—2022年)的通知. 国卫疾控发〔2019〕41号. 2019-05-31. |
[21] | 郭海萍, 逄宇. 全面落实肺结核诊断国家行业标准提高分子技术诊断耐药结核病能力. 结核与肺部疾病杂志, 2020,1(2):103-105. doi: 10.3969/j.issn.2096-8493.2020.02.001. |
[1] | Liang Linlong, Pei Yi, Zhou Haiyi, Xie Qifang, Zhang Feng, Jiang Jie, Liu Fuqiang. The epidemiological characteristics and trends of tuberculosis among children aged 0-14 years in Hunan Province from 2014 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 29-35. |
[2] | Lei Hui, Zhang Shu, Li Ting, Gao Yuan, Liu Shuang, Chen Chuang, Xia Lan, Wang Weina, Gao Wenfeng, He Jinge. Analysis of infection patterns and drug resistance of 22 recurrent pulmonary tuberculosis patients in Sichuan based on whole-genome sequencing [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 641-647. |
[3] | Song Yuanyuan, Li Tao, Xia Hui, Zhang Lijie, Zhang Hui, Zhao Yanlin, Wang Lixia. Analysis of the epidemiological characteristics of national reported pulmonary tuberculosis incidence, 1997—2023 [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1198-1208. |
[4] | Du Yongcheng, Lin Shufang, Dai Zhisong, Lin Jian. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Fujian Province from 2008 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1219-1226. |
[5] | Sun Jiaxuan, Liu Yan, Liang Pengfei, Zheng Yihui, Hu Yi, Chen Jing, Xu Biao. Screening of latent tuberculosis infection and analysis of morbidity influencing factors in household contacts of positive and sensitive pulmonary tuberculosis patients in Putuo District, Shanghai [J]. Chinese Journal of Antituberculosis, 2024, 46(1): 54-61. |
[6] | Gong Dehua, Tan Wenqian, Huang Juan, Wan Yanping, Xu Zuhui, Liu Zhaochun. Analysis of the detection delay and influencing factors of student with pulmonary tuberculosis in Hunan from 2011 to 2020 [J]. Chinese Journal of Antituberculosis, 2023, 45(3): 271-278. |
[7] | Zhang Wenqian, Huang Fei, Zhang Guoqin, Pang Xuewen, Zhang Fan. Temporal-spatial distribution of pulmonary tuberculosis in Tianjin during 2011—2022 [J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1170-1176. |
[8] | Li Jing, Gao Yuan, Lu Jia, He Jinge, Chen Chuang, Zhong Yin, Yang Ni, Xia Lan. Analysis of recurrence and influencing factors of tuberculosis patients in Sichuan Province within 2 years [J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1038-1044. |
[9] | Chen Daiquan, Lin Shufang, Zhou Yinfa, Chen Kun, Dai Zhisong. Patient delay and related factors among tuberculosis patient in Fujian Province, 2010—2019 [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 96-103. |
[10] | GAO Li, PANG Xue-wen, ZHANG Guo-qin, LI Jing-xin, ZHANG Fan. Analysis of risk factors for recurrence within 2 years after successful treatment of newly treated active pulmonary tuberculosis in Tianjin [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 698-703. |
[11] | XIE Bing-jie, JIN Fei, ZHANG Jun-li, XU Hua, CHEN Hai-feng, ZHANG Hui-min. Analysis of drug resistance among tuberculosis patients in Hebei Province in 2020 [J]. Chinese Journal of Antituberculosis, 2022, 44(4): 403-408. |
[12] | CHEN Jing, XIAO Xiao, WU Zhe-yuan, RAO Li-xin, WANG Juan, ZHANG Xia, SHEN Xin, YUAN Zheng-an. Screening of latent infection of Mycobacterium tuberculosis and analysis of influencing factors in elderly patients with type-2 diabetic mellitus in Xuhui and Changning Districts in Shanghai [J]. Chinese Journal of Antituberculosis, 2022, 44(2): 181-186. |
[13] | WANG Wei, YE Yi-nong, LIN Dong-zi, ZHONG Qian-hong, HUANG Fei, DU Fang-fang, CHENG Shi-ming, ZHOU Jie, ZHANG Xi-lin, ZHONG Qiu. Analysis of epidemiological characteristics of rifampicin resistance tuberculosis in Foshan City, Guangdong Province, 2011-2020 [J]. Chinese Journal of Antituberculosis, 2022, 44(2): 187-192. |
[14] | Zhang Xin, Lang Shengli, Bai Guohui, Gao Yulong, Xu Lijuan. Surveillance and analysis of tuberculosis in Inner Mongolia from 2011 to 2020 [J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1256-1261. |
[15] | ZHOU Yin-fa, LIN Shu-fang, DAI Zhi-song, Wei Shu-zhen, CHEN Dai-quan. Temporal-spatial distribution of pulmonary tuberculosis in Fujian Province during 2011—2020 [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 853-856. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||